Effects of fluoxetine at antidepressant doses on short-term outcome of detoxified alcoholics

International Clinical Psychopharmacology

Volumn 11, Issue 2, 1996, Pages 109-117

  Janiri, L ^a,b   Gobbi, G ^a   Mannelli, P ^a   Pozzi, G ^a   Serretti, A ^a   Tempesta, E ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Abstinence; Alcoholism; Compulsive behaviour; Fluoxetine; Outcome assessment

Indexed keywords

FLUOXETINE; PLACEBO;

ADULT; ALCOHOL ABSTINENCE; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPULSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DETOXIFICATION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0029882947     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199611020-00005     Document Type: Article

References (30)

1. Altamura AC, Montgomery SA and Wernicke JF (1988) The evidence for 20 mg a day of fluoxetine as the optimal dose in the treatment of depression. British Journal of Psychiatry, 153 (S3), 109-112.
2. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, revised. APA. Washington, DC.
3. Amit Z and Smith BR (1992) Neurotransmitter systems regulating alcohol intake. In: Novel Pharmacological Interventions for Alcoholism (Eds CA Naranjo and EM Sellers), pp. 161-183. Springer-Verlag, New York.
4. Babor TF, Hofmann M, Delboca FK, Hesselbrock V, Meyer RE, Dolinsky ZS and Rounsaville B (1992) Types of alcoholics, I. Evidence for an empirically derived typology based on indicators of vulnerability and severity. Archives of General Psychiatry, 49, 599-608.
5. Bruno F (1989) Buspirone in the treatment of alcoholic patients. Psychopathology, 22 (S1), 49-59.
6. Butterworth AF (1971) Depression associated with alcohol withdrawal: imipramine therapy compared with placebo. Quarterly Journal on Alcoholism, 32, 343-349.
7. Cloninger CR (1987) Neurogenetic adaptive mechanisms in alcoholism. Science, 236, 410-416.
8. Cottereau MJ, Tanios A and Chamballon O (1980) Alcoolisme et dépression. Encéphale, 6, 209-226.
9. Drummond DC (1990) The relationship between alcohol dependence and alcohol-related problems in a clinical population. British Journal of Addiction, 85, 357-366.
10. Edwards G, Brown D, Oppenheimer E, Sheehan M, Taylor C, Dukitt A (1988) Long-term outcome for patients with drinking problems: the search for predictors. British Journal of Addiction, 83, 917-927.
11. Edwards G and Gross MM (1976) Alcohol dependence: provisional description of a clinical syndrome. British Medical Journal, 1, 1058-1061.
12. Fontaine R and Chouinard G (1989) Fluoxetine in the long-term maintenance of obsessive compulsive disorder. Psychiatry Annals, 19, 88-91.
13. Glenn SW and Parsons OA (1991) Prediction of resumption of drinking in posttreatment alcoholics. International Journal of Addiction, 26, 237-254.
14. Gorelick GA and Paredes A (1992) Effect of fluoxetine on alcohol consumption in male alcoholics. Alcoholism: Clinical and Experimental Research, 16, 261-265.
15. Janiri L, Zeppetelli E, Di Matteo N, Gobbi G and Mannelli P (1991) A new rating scale for assessment of alcohol withdrawal syndrome (AWRS). Biological Psychiatry, 29, 284S.
16. Kosten TA and Kosten TR (1991) Criteria for diagnosis. In: Comprehensive Handbook of Alcohol and Drug Addiction (Ed. N. Miller), pp. 263-283. Marcel Dekker, New York.
17. Lawrin MO, Naranjo CA and Sellers EM (1986) Identification and testing of new drugs for modulating alcohol consumption. Psychopharmacology Bulletin, 22, 1020-1025.
18. Liebowitz MR, Hollander E, Schneier F, Campeas R, Hatterer J, Papp L, Fairbanks J, Sandberg D, Davies S and Stein M (1989) Fluoxetine treatment of obsessive-compulsive disorder: an open clinical trial. Journal of Clinical Psychopharmacology, 9, 423-427.
19. Marshall EJ and Murray RM (1991) The familial transmission of alcoholism: imitation and inheritance. British Medical Journal, 303, 72-73.
20. McLellan AT, Luborsky L, Woody GE, O'Brien CP and Druley KA (1983) Predicting response to alcohol and drug abuse treatments: role of psychiatric severity. Archives of General Psychiatry, 40, 620-625.
21. Miller NS and Gold MS (1989) Suggestions for changes in DSM-III-R criteria for substance abuse disorders. American Journal of Drug and Alcohol Abuse, 15, 223-230.
22. Naranjo CA and Bremner KE (1993) Clinical pharmacology of serotonin altering medications for decreasing alcohol consumption. Alcohol and Alcoholism, S2, 221-229.
23. Naranjo CA, Kadlec KE, Sanhueza P, Woodley-Remus D and Sellers EM (1990) Fluoxetine differentially alters alcohol and other consummatory behaviours in problem drinkers. Clinical Pharmacology and Therapeutics, 47, 490-498.
24. Naranjo CA, Poulos CX, Bremner KE and Lanctot KL (1994) Fluoxetine attenuates alcohol intake and desire to drink. International Clinical Psychopharmacology, 9, 163-172.
25. Rounsaville BJ, Dolinsky ZS, Babor TF and Meyer RE (1987) Psychopathology as a predictor of treatment outcome in alcoholics. Archives of General Psychiatry, 44, 503-513.
26. Skinner HS (1990) Validation of the dependence syndrome: have we crossed the half-life of this concept? In: The Nature of Drug Dependence (Eds G Edwards and M Lader), pp. 41-62. Oxford University Press.
27. Sullivan JT, Sykora K, Schneiderman J, Naranjo CA and Sellers EM (1989) Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). British Journal of Addiction, 84, 1353-1357.
28. Taylor C (1994) What happens over the long-term? British Medical Bulletin, 50, 50-66.
29. Tempesta E, Janiri L and Casacchia M (1991) Treatment of compulsivity in alcohol abuse. In: Biological Psychiatry (Eds G Racagni, N Brunello and T. Fukuda), Vol. 2, pp. 47-50. Elsevier, Amsterdam.
30. Wernicke JF, Janet C, Bosoworth J and Ashbrook E (1988) Fluoxetine at 20 mg per day: the recommended and therapeutic dose in the treatment of depression. International Clinical Psychopharmacology, 4, 63S-67S.